133 related articles for article (PubMed ID: 37741315)
1. Association of socioeconomic factors with the receipt of neoadjuvant therapy for patients with non-small cell lung cancer.
Elbahrawy MM; Kamel MK; Rodriguez-Quintero JH; Vimolratana M; Chudgar NP; Stiles BM
J Thorac Cardiovasc Surg; 2024 Apr; 167(4):1458-1466.e4. PubMed ID: 37741315
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
3. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
[TBL] [Abstract][Full Text] [Related]
4. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
6. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer.
Liu W; Zhang T; Zhang Q; Li L; Xu C
BMC Pulm Med; 2022 Dec; 22(1):490. PubMed ID: 36582007
[TBL] [Abstract][Full Text] [Related]
8. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
[TBL] [Abstract][Full Text] [Related]
9. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.
Billmeier SE; Ayanian JZ; Zaslavsky AM; Nerenz DR; Jaklitsch MT; Rogers SO
J Natl Cancer Inst; 2011 Nov; 103(21):1621-9. PubMed ID: 21960708
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
[TBL] [Abstract][Full Text] [Related]
11. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
12. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
14. Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?
Rodriguez-Quintero JH; Kamel MK; Jindani R; Zhu R; Friedmann P; Vimolratana M; Chudgar NP; Stiles B
Eur J Cardiothorac Surg; 2023 Dec; 64(6):. PubMed ID: 37952179
[TBL] [Abstract][Full Text] [Related]
15. The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database.
Rosen JE; Keshava HB; Yao X; Kim AW; Detterbeck FC; Boffa DJ
Ann Thorac Surg; 2016 May; 101(5):1850-5. PubMed ID: 27041452
[TBL] [Abstract][Full Text] [Related]
16. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
[TBL] [Abstract][Full Text] [Related]
17. Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
Sun C; Liu Y; Zhang P; Wang X; Xu Y; Lin X; Ma X; Guo Y; Qiu S; Shao G; Yang Z; Ma K
J Cancer Res Clin Oncol; 2023 Feb; 149(2):819-831. PubMed ID: 35192053
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Chemotherapy vs Chemoradiation Therapy Followed by Sleeve Resection for Resectable Lung Cancer.
Jaradeh M; Vigneswaran WT; Raad W; Lubawski J; Freeman R; Abdelsattar ZM
Ann Thorac Surg; 2022 Dec; 114(6):2041-2047. PubMed ID: 35351422
[TBL] [Abstract][Full Text] [Related]
19. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
20. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
